drugset / Trial / NCT01723722

Treatment of Neonatal Abstinence Syndrome

NCT01723722

Phase 4 Completed 40 enrolled Eastern Maine Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This study compares treatment of Neonatal Abstinence Syndrome (NAS) with two different drugs for the difference in the length of treatment. This is a randomized, open-label comparison of phenobarbital and methadone versus phenobarbital and diluted deodorized tincture of opium (dDTO) where phenobarbital is the initial drug used to stabilize neonatal withdrawal.

Timeline

Start
2007-01
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diluted Deodorized Tincture of Opium Unknown 0.1 mg/kg Oral
Comparator Diluted Deodorized Tincture of Opium Unknown 0.15 mg/kg Oral
Comparator Diluted Deodorized Tincture of Opium Unknown 0.2 mg/kg Oral
Comparator Diluted Deodorized Tincture of Opium Unknown 0.4 mg/kg Oral
Comparator Diluted Deodorized Tincture of Opium Unknown 0.6 mg/kg Oral
Comparator Diluted Deodorized Tincture of Opium Unknown 0.8 mg/kg Oral
Comparator Methadone Other / unclassified 0.05 mg/kg Oral
Comparator Methadone Other / unclassified 0.1 mg/kg Oral
Comparator Methadone Other / unclassified 0.15 mg/kg Oral